Tratamiento del síndrome antifosfolípido [PDF]
The antiphospholipid syndrome (APS) is a disorder of recurrent thrombosis and/or pregnancy loss associated with the presence of antiphospholipid antibodies and persistently positive lupus anticoagulant, anticardiolipin or anti beta2-glycoprotein1.
Garcia, R. (R.) +4 more
core
Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities [PDF]
Background : Observational studies suggest higher pregnancy rates after the hysteroscopic removal of endometrial polyps, submucous fibroids, uterine septum or intrauterine adhesions, which are detectable in 10% to 15% of women seeking treatment for ...
Bosteels, Jan +5 more
core +2 more sources
Biomimetic Fibrinogen Nanofiber Scaffolds for Vascular Hematopoietic Stem Cell Niche Engineering
This study presents an advanced in vitro model of the vascular hematopoietic stem cell niche using self‐assembled fibrinogen nanofibers, mimicking the basement membrane in bone marrow (BM) sinusoids. The model supports the coculture of microvascular endothelial cells, stromal cells, and hematopoietic stem and progenitor cells, providing insights into ...
Sophia Lena Meermeyer +4 more
wiley +1 more source
Recurrent Pregnancy Loss [Tekrarlayan Gebelik Kayiplari]
Recurrent pregnancy loss is an entity, that affects 0.5-3% of women with a wide etiology and treatment spectrum. A cause cannot be found in aproximately 50% of patients.
Senem Arda Duz
doaj +1 more source
Novel genes and mutations in patients affected by recurrent pregnancy loss. [PDF]
Recurrent pregnancy loss is a frequently occurring human infertility-related disease affecting ~1% of women. It has been estimated that the cause remains unexplained in >50% cases which strongly suggests that genetic factors may contribute towards the ...
Paula Quintero-Ronderos +8 more
doaj +1 more source
The Expression of microRNAs and Their Involvement in Recurrent Pregnancy Loss [PDF]
Background: Recurrent pregnancy loss refers to the spontaneous demise of two or more pregnancies before the 24 weeks of gestation. In almost half of the cases of recurrent miscarriages, the causes remain unknown since there is no reliable way of ...
Patronia M +14 more
europepmc +2 more sources
Role of the CD40–CD40L expression level pathway in the diagnosis of unexplained recurrent pregnancy loss [PDF]
Hui Ding, Guoqian An
openalex +1 more source
This study develops a placenta‐targeted nanodelivery system co‐loading HMGB1 protein and the NLRP3 agonist nigericin to establish an animal model of atonic postpartum hemorrhage. The model accurately recapitulates clinical phenotypes, including prolonged labor and uterine contractility dysfunction, while revealing inflammatory activation in placental ...
Jiangxue Qu +10 more
wiley +1 more source
This prospective cohort study aimed to evaluate the performance of Flora select™ (FS), a newly developed real-time PCR test, for the assessment of the vaginal microbiome during early pregnancy.
Hideto Yamada +6 more
doaj +1 more source
Current discourse on recurrent pregnancy loss (ESHRE Protocol 2023, National Clinical Guidelines "Recurrent Pregnancy Loss" 2021, materials of the World Congress of ESHRE 2023) [PDF]
Yu.E. Dobrokhotova, P.A. Kuznetsov, L.S. Dzhokhadze Pirogov Russian National Research Medical University, Moscow, Russian Federation In January 2023, European Society of Human Reproduction and Embryology (ESHRE) has released updated ...
Yu.E. Dobrokhotova +2 more
doaj

